posted Aug 19, 2016, 5:28 AM by Victor
updated Aug 19, 2016, 5:32 AM
August 19, 2016
A couple months late on this one, but back in July, a new type of buprenorphine treatment received FDA approval. The drug is branded under the name Probuphine and is being marketed as a buprenorphine implant that will last for 6-months, requiring only 2 treatments per year. This is an interesting development because both methadone and oral buprenorphine (Suboxone) maintenance - the two most dominant types of maintenance treatment for opioid addiction - both require that the patient dose daily.
Below was taken from an article about Probuphine on drugrehab.org. The page contains a lot of info and covers the most frequently asked questions. Read more below and check out the rest of the page, as it looks like a good starting resource to learn about this new opiate addiction treatment method.
FDA approves Probuphine, a six-month maintenance treatment
drugrehab.org - July 14, 2016
Death from opioid abuse
– including heroin and prescription painkillers – is at an all-time
high in the United States. But a new treatment option could be a “game
changer” in the fight against opioid addiction, experts say.
Probuphine®, a tiny implant inserted into the arm, delivers a
constant low dose of buprenorphine – a medication already used to treat
opioid addiction – for six months.
The implant offers advantages over taking a daily pill or sublingual
film of buprenorphine. Treatment compliance is far less of a challenge,
since patients can’t skip, forget or abuse their medication. They also
don’t have to deal with getting a prescription refilled. Some doctors
say the implant is safer and easier to tolerate because it delivers even
levels of buprenorphine into the bloodstream. The long-acting implant
also reduces the risk of accidental ingestion by a child, and diversion
of buprenorphine for illegal resale.
Continue reading at drugrehab.org...